Christa E Flück Selected Research

Electrolytes

1/2018	A rare cause of primary adrenal insufficiency due to a homozygous Arg188Cys mutation in the STAR gene.
1/2011	Loss of the C terminus of melanocortin receptor 2 (MC2R) results in impaired cell surface expression and ACTH insensitivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christa E Flück Research Topics

Disease

18	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2023 - 07/2006
11	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2023 - 08/2006
10	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2020 - 08/2006
10	Antley-Bixler Syndrome Phenotype 09/2017 - 03/2004
9	Virilism (Virilization) 01/2021 - 01/2008
8	Neoplasms (Cancer) 01/2021 - 01/2007
7	Starvation 01/2017 - 08/2010
6	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 11/2020 - 08/2011
6	Disorders of Sex Development (Intersexuality) 08/2020 - 05/2005
4	Lipoid congenital adrenal hyperplasia 01/2020 - 09/2005
4	Type II Isolated Growth Hormone Deficiency 01/2017 - 02/2010
3	Insulin Resistance 03/2024 - 03/2007
3	Hyperandrogenism 10/2023 - 03/2007
3	Obesity 06/2022 - 01/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 06/2003
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 06/2005
3	Addison Disease (Addison's Disease) 01/2018 - 02/2014
3	Craniosynostoses (Craniosynostosis) 01/2011 - 12/2005
3	Hypoglycemia (Reactive Hypoglycemia) 01/2011 - 06/2003
2	Weight Gain 02/2024 - 06/2022
2	Weight Loss (Weight Reduction) 06/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 04/2018 - 01/2017
2	Hyperpigmentation 01/2018 - 09/2002
2	Cortisone reductase deficiency 11/2015 - 01/2014
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2014 - 01/2013
2	Turner Syndrome (Turner's Syndrome) 07/2013 - 01/2012
2	Hyperplasia 01/2011 - 09/2005
1	Acanthosis Nigricans 03/2024
1	Hypertrichosis 03/2024
1	Nephrocalcinosis 03/2024
1	Hirsutism 10/2023
1	Perinatal Death 01/2023
1	Isolated Mineralocorticoid Deficiency 01/2023
1	Deafness (Deaf Mutism) 01/2023
1	Failure to Thrive 01/2023
1	Hypoaldosteronism (Hyporeninemic Hypoaldosteronism) 01/2023
1	Hyperphagia (Overeating) 06/2022
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Infertility (Sterility) 01/2022
1	Acne Vulgaris 01/2021
1	Ovarian Torsion 04/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Meningioma (Meningiomas) 01/2019

Drug/Important Bio-Agent (IBA)

20	AndrogensIBA 02/2024 - 03/2007
20	SteroidsIBA 01/2020 - 09/2005
16	Oxidoreductases (Dehydrogenase)IBA 01/2020 - 03/2004
14	EnzymesIBA 04/2018 - 03/2004
7	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2010
7	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2022 - 09/2002
6	GlucocorticoidsIBA 01/2023 - 12/2007
6	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 04/2018 - 08/2006
6	3 beta-hydroxysteroid dehydrogenase type IIIBA 01/2016 - 08/2010
5	Insulin (Novolin)FDA Link 03/2024 - 06/2005
5	Hormones (Hormone)IBA 01/2021 - 06/2010
5	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020 - 01/2011
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2020 - 03/2004
4	Growth Hormone (Somatotropin)IBA 01/2019 - 06/2010
3	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 06/2005
3	SaltsIBA 01/2023 - 07/2006
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 09/2012
3	steroidogenic acute regulatory proteinIBA 01/2020 - 09/2005
3	Dihydrotestosterone (Androstanolone)IBA 01/2017 - 01/2008
3	MineralocorticoidsIBA 01/2016 - 09/2002
3	Insulin-Like Growth Factor I (IGF-1)IBA 12/2015 - 02/2010
3	Transcription Factors (Transcription Factor)IBA 01/2014 - 06/2005
3	Mixed Function Oxygenases (Monooxygenases)IBA 09/2012 - 08/2006
3	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 08/2006 - 05/2005
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2013
2	AldosteroneIBA 01/2023 - 02/2014
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 11/2020
2	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 08/2020 - 08/2006
2	Aromatase deficiencyIBA 04/2020 - 06/2014
2	ElectrolytesIBA 01/2018 - 01/2011
2	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2013
2	Estrogens (Estrogen)FDA Link 01/2017 - 01/2012
2	Vitamin D FDA LinkGeneric 01/2016 - 01/2010
2	Aromatase (CYP19)IBA 06/2014 - 11/2007
2	Estriol (Epiestriol)IBA 01/2011 - 01/2008
1	Valine (L-Valine)FDA Link 03/2024
1	Alanine (L-Alanine)FDA Link 03/2024
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 06/2022
1	SubtilisinIBA 06/2022
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 06/2022
1	setmelanotideIBA 06/2022
1	Leptin ReceptorsIBA 06/2022
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 06/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	elexacaftorIBA 01/2022
1	ivacaftor drug combination tezacaftorIBA 01/2022
1	C 73IBA 01/2020
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 01/2019
1	efavirenz (Sustiva)FDA Link 01/2019
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 01/2019
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2019
1	Emtricitabine (Emtriva)FDA Link 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	abirateroneIBA 04/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2005
2	Castration 01/2018 - 01/2017
1	Radiotherapy 01/2019